Alpine Global Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Alpine Global Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,260	Closed	-$480K	–	130
2019 Q1	$480K	Buy	+5,260	New	+$430K	0.14%	51
2015 Q3	–	Sell	-1,100	Closed	-$127K	–	1069
2015 Q2	$127K	Buy	+1,100	New	+$116K	0.02%	521

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GAM

Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alpine Global Management's CBPO Position: Q2 2019 in Review

Alpine Global Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2019, closing a stake of 5,260 shares — an estimated $480K sold.

Alpine Global Management first reported a position in CBPO in Q2 2015 and held it in 2 quarters. The position peaked at $480K in Q1 2019. 71 funds tracked by Wall St. Rank hold CBPO as of Q2 2019.

Alpine Global Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2019 after selling out during the quarter.
Alpine Global Management sold 5,260 China Biologic Products Holdings, Inc. shares in Q2 2019, an estimated $480K.
Alpine Global Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 2 quarters.
Alpine Global Management's China Biologic Products Holdings, Inc. position peaked at $480K in Q1 2019.
71 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2019.

Based on Alpine Global Management's 13F filing for Q2 2019, filed 12 Jul 2019.